Predicted protein targets (top 3)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | EDNRB | P24530 | 3/20 | 0.33 |
| ▸ | EDNRA | P25101 | 3/20 | 0.33 |
| ▸ | KCNA5 | P22460 | 1/20 | 0.32 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL20920142 | 0.78 | LMNA (0.34) | EDNRBEDNRAKCNA5 | |
| SCHEMBL17600574 | 0.75 | KCNA5 (0.33) | KCNA5 | |
| SCHEMBL1059507 | 0.74 | EDNRB (0.42) | EDNRBEDNRA | |
| SCHEMBL1059509 | 0.74 | EDNRB (0.42) | EDNRBEDNRA | |
| SCHEMBL1059493 | 0.74 | MAPK1 (0.34) | EDNRBEDNRAKCNA5 | |
| SCHEMBL1059491 | 0.74 | MAPK1 (0.34) | EDNRBEDNRAKCNA5 | |
| Chloromethane SCHEMBL27769943 | 0.73 | LTA4H (0.34) | — | |
| SCHEMBL648156 | 0.73 | LTA4H (0.34) | — | |
| SCHEMBL29900 | 0.73 | LTA4H (0.37) | — | |
| SCHEMBL6036928 | 0.71 | CA12 (0.36) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-3000804-B1 | TRIPHENYLAMINE DERIVATIVE AND USE THEREFOR | NISSAN CHEMICAL IND LTD (JP) | 2018-04-25 | — | — | EP | disclosed |
| US-9780309-B2 | Triphenylamine derivative and use therefor | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2017-10-03 | — | — | US | disclosed |
| EP-3000804-A1 | TRIPHENYLAMINE DERIVATIVE AND USE THEREFOR | Nissan Chemical Industries, Ltd. (JP) | 2016-03-30 | — | — | EP | disclosed |
| US-20160087220-A1 | TRIPHENYLAMINE DERIVATIVE AND USE THEREFOR | NISSAN CHEMICAL INDUSTRIES, LTD. (JP) | 2016-03-24 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20160087220-A1 | TRIPHENYLAMINE DERIVATIVE AND USE THEREFOR | SLC7A1, SLC7A5, SLC7A11 | EDNRB 1326/4885EDNRA 1206/4885KCNA5 1823/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.